Tumor dynamics in patients with solid tumors treated with pembrolizumab beyond disease progression
Cancer Cell · 2023-09 · 41 (9) · 1680-1688.e2
DOI: 10.1016/j.ccell.2023.08.004 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancer Cell, 2023-09. Verfasst von Brian G Topp und 7 weiteren Autor:innen. Beteiligte Einrichtung: Merck & Co., Inc, Rahway, NJ, USA. Electronic address: brian.topp@merck.com. Hauptthemen laut MEDLINE: Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Carcinoma, Transitional Cell, Urinary Bladder Neoplasms. Die Arbeit wurde bisher 40-mal zitiert (Crossref) und nennt 20 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NCI NIH HHS, Merck Sharp and Dohme.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Merck & Co., Inc, Rahway, NJ, USA. Electronic address: brian.topp@merck.com.
- Vantage Research, Chennai, India.
- Merck & Co., Inc, Rahway, NJ, USA.
- Meyer Cancer Center, Weill Cornell Medicine, New York, NY, USA.
- UCLA, Los Angeles, CA, USA.
Förderung
- NCI NIH HHS
- Merck Sharp and Dohme
Zitieren
APA
Topp, B. G., Channavazzala, M., Mayawala, K., De Alwis, D. P., Rubin, E., Snyder, A., Wolchok, J. D., & Ribas, A. (2023). Tumor dynamics in patients with solid tumors treated with pembrolizumab beyond disease progression. Cancer Cell, 41(9), 1680-1688.e2. https://doi.org/10.1016/j.ccell.2023.08.004
Vancouver
Topp BG, Channavazzala M, Mayawala K, De Alwis DP, Rubin E, Snyder A, et al. Tumor dynamics in patients with solid tumors treated with pembrolizumab beyond disease progression. Cancer Cell. 2023;41(9):1680-1688.e2. doi:10.1016/j.ccell.2023.08.004
BibTeX
@article{Topp2023,
author = {Topp, Brian G and Channavazzala, Madhav and Mayawala, Kapil and De Alwis, Dinesh P and Rubin, Eric and Snyder, Alexandra and Wolchok, Jedd D and Ribas, Antoni},
title = {Tumor dynamics in patients with solid tumors treated with pembrolizumab beyond disease progression},
journal = {Cancer Cell},
year = {2023},
volume = {41},
number = {9},
pages = {1680--1688.e2},
doi = {10.1016/j.ccell.2023.08.004}
}
EUVIMED